NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Plum Raises Rs 193 Crore in Series B Funding Round

Plum, a Bengaluru-based employee health benefits platform, has secured Rs 193 crore in a Series B funding round led by Peak XV Partners. Existing investor Tanglin Venture Partners and new backer GMO Venture Partners also participated in the round.

The fresh capital will be deployed towards enhancing technology, talent acquisition, enterprise-grade security, and scaling AI-driven claims operations. Additionally, the company plans to expand integrations with HR and payroll systems while broadening its healthcare stack across preventive care, primary care, mental wellness, and telehealth.

Founded in 2019 by Abhishek Poddar and Saurabh Arora, Plum operates an employee health benefits platform that enables companies to offer insurance and healthcare services to their workforce. The company currently serves over 6,000 organisations, including startups and large enterprises such as CRED, Meesho, PhonePe, and Swiggy, covering more than 600,000 employees.

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

In its previous funding round, Plum raised $15 million in its Series A round in 2021, led by Tiger Global and backed by Peak XV’s Surge, Tanglin Venture Partners, Incubate Fund, and Gemba Capital. The company reported Rs 70 crore in revenue in FY25, with six months of EBITDA profitability.

The fundraise comes after Plum reported its first full year of EBITDA and cash flow profitability, signalling a shift towards sustainable growth in the broader insurtech sector. Since inception, the company has processed over 500,000 claims and reduced median hospital discharge time to 47 minutes, while bringing reimbursement turnaround time down to 1.5 days.

Investor Takeaway

Investors should consider the growth potential of insurtech firms like Plum, which are scaling their employee health benefits platforms.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.